Case for stopping targeted therapy when lung cancer progresses on treatment in hospice-eligible patients Journal Article
| Authors: | Smith, T. J.; Hanna, N.; Johnson, D.; Baker, S. Jr; Biermann, W. A.; Brahmer, J.; Ellis, P. M.; Giaccone, G.; Hesketh, P. J.; Jaiyesimi, I.; Leighl, N. B.; Riely, G. J.; Schiller, J. H.; Schneider, B. J.; Tashbar, J.; Temin, S.; Masters, G. |
| Article Title: | Case for stopping targeted therapy when lung cancer progresses on treatment in hospice-eligible patients |
| Keywords: | adult; cancer chemotherapy; clinical article; treatment response; middle aged; review; case report; percutaneous endoscopic gastrostomy; erlotinib; cancer growth; drug withdrawal; cancer patient; cancer palliative therapy; epidermal growth factor receptor; evidence based practice; hemoglobin; drug cost; lung adenocarcinoma; thrombocyte count; cachexia; treatment withdrawal; small intestine obstruction; carcinomatosis; hydronephrosis; hospice care; molecularly targeted therapy; anasarca; eastern cooperative oncology group performance status; malignant pleura effusion; hospice patient; human; female; osimertinib; functional status assessment |
| Journal Title: | Journal of Oncology Practice |
| Volume: | 13 |
| Issue: | 12 |
| ISSN: | 1554-7477 |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2017-12-01 |
| Start Page: | 780 |
| End Page: | 783 |
| Language: | English |
| DOI: | 10.1200/jop.2017.027367 |
| PROVIDER: | scopus |
| PUBMED: | 28981389 |
| DOI/URL: | |
| Notes: | Review -- Export Date: 1 February 2018 -- Source: Scopus |
